Lucid Diagnostics Inc. (LUCD) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -50.68M USD | Operating Income (Loss) |
| Revenue | (m) | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 5.39M USD | Research and Development Expense |
| Selling, general and administration | (m) | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-50.68M | (m) | (m) | $5.39M | (m) | (m) |
| 2026-03-31 | $-49.27M | (m) | (m) | $5.46M | (m) | (m) |
| 2025-12-31 | $-49.64M | (m) | (m) | $5.68M | (m) | (m) |
| 2025-09-30 | $-48.00M | $4.40M | (m) | $5.41M | (m) | -1091.25% |
| 2025-06-30 | $-47.94M | $4.36M | (m) | $5.80M | (m) | -1099.54% |
| 2025-03-31 | $-47.75M | $4.17M | (m) | $5.92M | (m) | -1144.19% |
| 2024-12-31 | $-46.05M | $4.35M | (m) | $5.99M | (m) | -1059.64% |
| 2024-09-30 | $-45.13M | $4.19M | (m) | $6.46M | (m) | -1077.35% |
| 2024-06-30 | $-44.56M | $3.80M | (m) | $6.41M | (m) | -1172.76% |
| 2024-03-31 | $-44.96M | $2.98M | (m) | $6.86M | (m) | -1507.11% |
| 2023-12-31 | $-48.48M | $2.43M | (m) | $7.25M | (m) | -1996.79% |
| 2023-09-30 | $-51.92M | $1.50M | (m) | $7.99M | (m) | -3461.60% |
| 2023-06-30 | $-55.17M | $793.00K | (m) | $9.25M | (m) | -6957.38% |
| 2023-03-31 | $-58.22M | $634.00K | (m) | $10.87M | (m) | -9182.49% |
| 2022-12-31 | $-56.17M | $377.00K | $100.00M | $11.47M | (m) | -14899.47% |
| 2022-09-30 | $-52.48M | $565.00K | (m) | $12.51M | (m) | -9289.20% |
| 2022-06-30 | $-44.64M | $689.00K | (m) | $11.99M | (m) | -6479.54% |
| 2022-03-31 | $-35.86M | (m) | (m) | $10.43M | (m) | (m) |
| 2021-12-31 | $-27.42M | $500.00K | (m) | $9.30M | $21.00K | -5483.80% |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-8.28M | (m) | (m) | $5.44M | $7.00K | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |